BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 17362525)

  • 1. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study.
    Kofoed K; Andersen O; Kronborg G; Tvede M; Petersen J; Eugen-Olsen J; Larsen K
    Crit Care; 2007; 11(2):R38. PubMed ID: 17362525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of soluble urokinase plasminogen activator receptor, soluble triggering receptor expressed on myeloid cells 1, procalcitonin and C-reactive protein in distinguishing concurrent bacterial infection from idiopathic inflammatory myopathy.
    Xiao Y; Luo H; Zhou B; Dai X; Huang J; Duan L; You Y; Zhang W; Zhao H; Xie Y; Zhou Y; Ning W; Li T; Liu S; Zhu H; Xie X; Jiang Y; Wu S; He W; Li Y
    Rheumatol Int; 2017 Apr; 37(4):585-592. PubMed ID: 27878344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic stone protein as a novel marker for neonatal sepsis.
    Schlapbach LJ; Graf R; Woerner A; Fontana M; Zimmermann-Baer U; Glauser D; Giannoni E; Roger T; Müller C; Nelle M; Stocker M
    Intensive Care Med; 2013 Apr; 39(4):754-63. PubMed ID: 23296629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome.
    Hoenigl M; Raggam RB; Wagner J; Valentin T; Leitner E; Seeber K; Zollner-Schwetz I; Krammer W; Prüller F; Grisold AJ; Krause R
    Clin Biochem; 2013 Feb; 46(3):225-9. PubMed ID: 23159293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor.
    Kofoed K; Eugen-Olsen J; Petersen J; Larsen K; Andersen O
    Eur J Clin Microbiol Infect Dis; 2008 May; 27(5):375-83. PubMed ID: 18197443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study.
    Su L; Han B; Liu C; Liang L; Jiang Z; Deng J; Yan P; Jia Y; Feng D; Xie L
    BMC Infect Dis; 2012 Jul; 12():157. PubMed ID: 22809118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of high-mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community-acquired infections and bacteraemia: a prospective study.
    Gaïni S; Koldkjaer OG; Møller HJ; Pedersen C; Pedersen SS
    Crit Care; 2007; 11(4):R76. PubMed ID: 17625012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of decoy receptor 3 combined with procalcitonin and soluble urokinase-type plasminogen activator receptor for sepsis.
    Zhao JJ; Lou XL; Chen HW; Zhu FT; Hou YQ
    Cell Mol Biol Lett; 2018; 23():22. PubMed ID: 29760745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis.
    Ljungström L; Pernestig AK; Jacobsson G; Andersson R; Usener B; Tilevik D
    PLoS One; 2017; 12(7):e0181704. PubMed ID: 28727802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective Evaluation of Procalcitonin, Soluble Triggering Receptor Expressed on Myeloid Cells-1 and C-Reactive Protein in Febrile Patients with Autoimmune Diseases.
    Lin CH; Hsieh SC; Keng LT; Lee HS; Chang HT; Liao WY; Ho CC; Yu CJ
    PLoS One; 2016; 11(4):e0153938. PubMed ID: 27096761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein, procalcitonin and the lab-score for detecting serious bacterial infections in febrile children at the emergency department: a prospective observational study.
    Nijman RG; Moll HA; Smit FJ; Gervaix A; Weerkamp F; Vergouwe Y; de Rijke YB; Oostenbrink R
    Pediatr Infect Dis J; 2014 Nov; 33(11):e273-9. PubMed ID: 25093971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The accuracy of C-reactive protein, procalcitonin, and s-TREM-1 in the prediction of serious bacterial infection in neonates.
    Stein M; Schachter-Davidov A; Babai I; Tasher D; Somekh E
    Clin Pediatr (Phila); 2015 May; 54(5):439-44. PubMed ID: 25294884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of dynamics serum sCD163, sTREM-1, PCT, and CRP in differentiating sepsis, severity assessment, and prognostic prediction.
    Su L; Feng L; Song Q; Kang H; Zhang X; Liang Z; Jia Y; Feng D; Liu C; Xie L
    Mediators Inflamm; 2013; 2013():969875. PubMed ID: 23935252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis.
    Gibot S; Cravoisy A; Kolopp-Sarda MN; Béné MC; Faure G; Bollaert PE; Levy B
    Crit Care Med; 2005 Apr; 33(4):792-6. PubMed ID: 15818107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome.
    Raggam RB; Wagner J; Prüller F; Grisold A; Leitner E; Zollner-Schwetz I; Valentin T; Krause R; Hoenigl M
    J Intern Med; 2014 Dec; 276(6):651-8. PubMed ID: 24645798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?
    Pereira JM; Teixeira-Pinto A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
    J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis.
    Huang CT; Lee LN; Ho CC; Shu CC; Ruan SY; Tsai YJ; Wang JY; Yu CJ
    J Infect; 2014 May; 68(5):440-7. PubMed ID: 24393650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble urokinase-type plasminogen activator receptor in patients with suspected infection in the emergency room: a prospective cohort study.
    Uusitalo-Seppälä R; Huttunen R; Tarkka M; Aittoniemi J; Koskinen P; Leino A; Vahlberg T; Rintala EM
    J Intern Med; 2012 Sep; 272(3):247-56. PubMed ID: 22755554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble receptor for urokinase plasminogen activator in community-acquired pneumonia in children.
    Wrotek A; Pawlik K; Jackowska T
    Adv Exp Med Biol; 2013; 788():329-34. PubMed ID: 23835994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Procalcitonin Assays to Predict Serious Bacterial Infection in Young Febrile Infants.
    Milcent K; Faesch S; Gras-Le Guen C; Dubos F; Poulalhon C; Badier I; Marc E; Laguille C; de Pontual L; Mosca A; Nissack G; Biscardi S; Le Hors H; Louillet F; Dumitrescu AM; Babe P; Vauloup-Fellous C; Bouyer J; Gajdos V
    JAMA Pediatr; 2016 Jan; 170(1):62-9. PubMed ID: 26595253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.